Latest filing published 01 Sept 2026 for Abionyx Pharma.
Filing timeline
BuySaleInsider track record
Emmanuel Huynh: trading record in brief
Emmanuel Huynh, listed as senior executive, appears in our data through filings on Abionyx Pharma shares, published by AMF. We count 5 filings; the first trade dates from 3 December 2021 and the latest from 24 August 2026.
Every open-market trade on record is a sale: 1 sale worth €32k. Besides market trades, the filings include 3 share grants.
Most recently, on 1 September 2026, the filings show a share grant in Abionyx Pharma. Typically, a trade is published a median of 4 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to Emmanuel Huynh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 314,379 shares0ActionEuronext ParisISIN FR00126168522026DD1135498
- 314,379 shares0ActionEuronext ParisISIN FR00126168522026DD1135092
- 10,000 shares@ €3.235100.0% of flowActionEuronext ParisISIN FR00126168522025DD1086325
- 125,000 shares0ActionEuronext ParisISIN FR00126168522022DD872749
- 208,333 shares@ €3.60100.0% of flowActionEuronext ParisISIN FR00126168522021DD801177
5 of 5 declarations
